GCP2 Bovine

Granulocyte Chemotactic Protein 2 (CXCL6) Bovine Recombinant

Granulocyte Chemotactic Protein 2 (CXCL6) Bovine Recombinant produced in E.Coli is a non-glycosylated polypeptide chain containing 76 amino acids and having a molecular mass of approximately 8.0kDa.
GCP2 is purified by proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT10580
Source

Escherichia Coli.

Appearance

Sterile Filtered White lyophilized (freeze-dried) powder.

GCP-2 Human

Granulocyte Chemotactic Protein 2 (CXCL6) Human Recombinant

GCP-2 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 72 amino acids and having a molecular mass of 7.9kDa.
Shipped with Ice Packs
Cat. No.
BT10666
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Definition and Classification

CXCL6, also known as granulocyte chemotactic protein-2 (GCP-2), is a small cytokine belonging to the CXC chemokine family . It is a chemoattractant for neutrophilic granulocytes and interacts with chemokine receptors CXCR1 and CXCR2 .

Biological Properties

Key Biological Properties: CXCL6 is chemotactic for neutrophil granulocytes and has strong antibacterial activity against both Gram-positive and Gram-negative bacteria .

Expression Patterns and Tissue Distribution: CXCL6 is expressed in various tissues, including bronchial epithelial cells, spleen, olfactory zone of nasal mucosa, cartilage tissue, and islet of Langerhans beta cells . It is also found in the right lobe of the liver, cervix, endothelial cells of lymphatic vessels, and trachea .

Biological Functions

Primary Biological Functions: CXCL6 plays a crucial role in recruiting neutrophils to sites of inflammation, thereby contributing to non-specific immunity . It also has angiogenic properties and promotes tissue repair .

Role in Immune Responses and Pathogen Recognition: CXCL6 is involved in the immune response by attracting neutrophils to infection sites, enhancing the body’s ability to fight off pathogens .

Modes of Action

Mechanisms with Other Molecules and Cells: CXCL6 exerts its effects by binding to chemokine receptors CXCR1 and CXCR2 . This interaction triggers downstream signaling pathways that lead to chemotaxis and activation of neutrophils .

Binding Partners and Downstream Signaling Cascades: The binding of CXCL6 to CXCR1 and CXCR2 activates G protein-coupled receptor signaling pathways, leading to various cellular responses, including chemotaxis and activation of immune cells .

Regulatory Mechanisms

Regulatory Mechanisms Controlling Expression and Activity: The expression of CXCL6 is regulated by various factors, including cancer-related genes and interleukin family members . These factors can promote the abnormal secretion of CXCL6, which in turn affects tumor growth and metastasis .

Transcriptional Regulation and Post-Translational Modifications: Specific transcription factors and kinases, such as RELA, NFKB1, LCK, and PAK2, play a role in the transcriptional regulation of CXCL6 . Post-translational modifications, such as phosphorylation, may also influence its activity .

Applications

Biomedical Research: CXCL6 is a potential therapeutic target for inflammation and cancer due to its role in recruiting neutrophils and promoting angiogenesis .

Diagnostic Tools and Therapeutic Strategies: Elevated levels of CXCL6 can serve as biomarkers for diseases such as idiopathic pulmonary fibrosis and various cancers . Therapeutic strategies targeting CXCL6 and its receptors are being explored for their potential to modulate immune responses and inhibit tumor progression .

Role in the Life Cycle

Role Throughout the Life Cycle: CXCL6 plays a role in various stages of life, from development to aging and disease. During development, it is involved in tissue repair and immune responses . In aging, its dysregulation can contribute to chronic inflammatory conditions and cancer .

© Copyright 2024 Thebiotek. All Rights Reserved.